Cargando…

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia

Nowadays, Alzheimer’s disease (AD) is a severe sociological and clinical problem. Since it was first described, there has been a constant increase in its incidence and, for now, there are no effective treatments since current approved medications have only shown short-term symptomatic benefits. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Folch, Jaume, Olloquequi, Jordi, Ettcheto, Miren, Busquets, Oriol, Sánchez-López, Elena, Cano, Amanda, Espinosa-Jiménez, Triana, García, Maria Luisa, Beas-Zarate, Carlos, Casadesús, Gemma, Bulló, Mónica, Auladell, Carme, Camins, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743006/
https://www.ncbi.nlm.nih.gov/pubmed/31551756
http://dx.doi.org/10.3389/fnagi.2019.00236
_version_ 1783451201443987456
author Folch, Jaume
Olloquequi, Jordi
Ettcheto, Miren
Busquets, Oriol
Sánchez-López, Elena
Cano, Amanda
Espinosa-Jiménez, Triana
García, Maria Luisa
Beas-Zarate, Carlos
Casadesús, Gemma
Bulló, Mónica
Auladell, Carme
Camins, Antoni
author_facet Folch, Jaume
Olloquequi, Jordi
Ettcheto, Miren
Busquets, Oriol
Sánchez-López, Elena
Cano, Amanda
Espinosa-Jiménez, Triana
García, Maria Luisa
Beas-Zarate, Carlos
Casadesús, Gemma
Bulló, Mónica
Auladell, Carme
Camins, Antoni
author_sort Folch, Jaume
collection PubMed
description Nowadays, Alzheimer’s disease (AD) is a severe sociological and clinical problem. Since it was first described, there has been a constant increase in its incidence and, for now, there are no effective treatments since current approved medications have only shown short-term symptomatic benefits. Therefore, it is imperative to increase efforts in the search for molecules and non-pharmacological strategies that are capable of slowing or stopping the progress of the disease and, ideally, to reverse it. The amyloid cascade hypothesis based on the fundamental role of amyloid has been the central hypothesis in the last 30 years. However, since amyloid-directed treatments have shown no relevant beneficial results other theories have been postulated to explain the origin of the pathology. The brain is a highly metabolically active energy-consuming tissue in the human body. It has an almost complete dependence on the metabolism of glucose and uses most of its energy for synaptic transmission. Thus, alterations on the utilization or availability of glucose may be cause for the appearance of neurodegenerative pathologies like AD. In this review article, the hypothesis known as Type 3 Diabetes (T3D) will be evaluated by summarizing some of the data that has been reported in recent years. According to published research, the adherence over time to low saturated fatty acids diets in the context of the Mediterranean diet would reduce the inflammatory levels in brain, with a decrease in the pro-inflammatory glial activation and mitochondrial oxidative stress. In this situation, the insulin receptor pathway would be able to fine tune the mitochondrial biogenesis in neuronal cells, regulation the adenosine triphosphate/adenosine diphosphate intracellular balance, and becoming a key factor involved in the preservation of the synaptic connexions and neuronal plasticity. In addition, new targets and strategies for the treatment of AD will be considered in this review for their potential as new pharmacological or non-pharmacological approaches.
format Online
Article
Text
id pubmed-6743006
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67430062019-09-24 The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia Folch, Jaume Olloquequi, Jordi Ettcheto, Miren Busquets, Oriol Sánchez-López, Elena Cano, Amanda Espinosa-Jiménez, Triana García, Maria Luisa Beas-Zarate, Carlos Casadesús, Gemma Bulló, Mónica Auladell, Carme Camins, Antoni Front Aging Neurosci Neuroscience Nowadays, Alzheimer’s disease (AD) is a severe sociological and clinical problem. Since it was first described, there has been a constant increase in its incidence and, for now, there are no effective treatments since current approved medications have only shown short-term symptomatic benefits. Therefore, it is imperative to increase efforts in the search for molecules and non-pharmacological strategies that are capable of slowing or stopping the progress of the disease and, ideally, to reverse it. The amyloid cascade hypothesis based on the fundamental role of amyloid has been the central hypothesis in the last 30 years. However, since amyloid-directed treatments have shown no relevant beneficial results other theories have been postulated to explain the origin of the pathology. The brain is a highly metabolically active energy-consuming tissue in the human body. It has an almost complete dependence on the metabolism of glucose and uses most of its energy for synaptic transmission. Thus, alterations on the utilization or availability of glucose may be cause for the appearance of neurodegenerative pathologies like AD. In this review article, the hypothesis known as Type 3 Diabetes (T3D) will be evaluated by summarizing some of the data that has been reported in recent years. According to published research, the adherence over time to low saturated fatty acids diets in the context of the Mediterranean diet would reduce the inflammatory levels in brain, with a decrease in the pro-inflammatory glial activation and mitochondrial oxidative stress. In this situation, the insulin receptor pathway would be able to fine tune the mitochondrial biogenesis in neuronal cells, regulation the adenosine triphosphate/adenosine diphosphate intracellular balance, and becoming a key factor involved in the preservation of the synaptic connexions and neuronal plasticity. In addition, new targets and strategies for the treatment of AD will be considered in this review for their potential as new pharmacological or non-pharmacological approaches. Frontiers Media S.A. 2019-09-06 /pmc/articles/PMC6743006/ /pubmed/31551756 http://dx.doi.org/10.3389/fnagi.2019.00236 Text en Copyright © 2019 Folch, Olloquequi, Ettcheto, Busquets, Sánchez-López, Cano, Espinosa-Jiménez, García, Beas-Zarate, Casadesús, Bulló, Auladell and Camins. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Folch, Jaume
Olloquequi, Jordi
Ettcheto, Miren
Busquets, Oriol
Sánchez-López, Elena
Cano, Amanda
Espinosa-Jiménez, Triana
García, Maria Luisa
Beas-Zarate, Carlos
Casadesús, Gemma
Bulló, Mónica
Auladell, Carme
Camins, Antoni
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
title The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
title_full The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
title_fullStr The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
title_full_unstemmed The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
title_short The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
title_sort involvement of peripheral and brain insulin resistance in late onset alzheimer’s dementia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743006/
https://www.ncbi.nlm.nih.gov/pubmed/31551756
http://dx.doi.org/10.3389/fnagi.2019.00236
work_keys_str_mv AT folchjaume theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT olloquequijordi theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT ettchetomiren theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT busquetsoriol theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT sanchezlopezelena theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT canoamanda theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT espinosajimeneztriana theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT garciamarialuisa theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT beaszaratecarlos theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT casadesusgemma theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT bullomonica theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT auladellcarme theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT caminsantoni theinvolvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT folchjaume involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT olloquequijordi involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT ettchetomiren involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT busquetsoriol involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT sanchezlopezelena involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT canoamanda involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT espinosajimeneztriana involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT garciamarialuisa involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT beaszaratecarlos involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT casadesusgemma involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT bullomonica involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT auladellcarme involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia
AT caminsantoni involvementofperipheralandbraininsulinresistanceinlateonsetalzheimersdementia